Lv et al. reported an abrogation of the excessive immune response in a mouse infection model after applying H151, as well as a reduced activation of the NLRP3 inflammasome-associated production of IL-1β in aged human peripheral blood mononuclear cells (PBMCs), thus improving the course of disease and the outcome [17]. The gene discussed is IL1B; the disease is infection.